Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Efficacy of preventing hemodialysis catheter infections with citrate lock.

Silva J, Antunes J, Carvalho T, Ponce P.

Hemodial Int. 2012 Oct;16(4):545-52. doi: 10.1111/j.1542-4758.2012.00691.x. Epub 2012 Apr 20.

PMID:
22515732
2.

Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.

Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P.

Am J Kidney Dis. 2014 Mar;63(3):479-90. doi: 10.1053/j.ajkd.2013.08.016. Epub 2013 Oct 11. Review.

PMID:
24125729
3.

Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.

Silva TN, Mendes ML, AbrĂ£o JM, Caramori JT, Ponce D.

Int Urol Nephrol. 2013 Oct;45(5):1405-13. doi: 10.1007/s11255-012-0339-1. Epub 2012 Dec 27.

PMID:
23269457
4.

A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.

Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B.

Am J Kidney Dis. 2012 Jan;59(1):102-7. doi: 10.1053/j.ajkd.2011.08.031. Epub 2011 Nov 14.

PMID:
22088576
5.

Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.

Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H.

J Am Soc Nephrol. 2002 Aug;13(8):2133-9.

6.

Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.

Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D.

Am J Kidney Dis. 2009 Jun;53(6):1034-41. doi: 10.1053/j.ajkd.2009.01.259. Epub 2009 Apr 25.

PMID:
19394731
7.

Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.

Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, Zervos MJ, Adams E, Yee J.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1232-9. doi: 10.2215/CJN.11291113. Epub 2014 Jun 26.

8.

Antibiotic lock: in vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37 degrees C.

Battistella M, Walker S, Law S, Lok C.

Hemodial Int. 2009 Jul;13(3):322-8. doi: 10.1111/j.1542-4758.2009.00368.x. Epub 2009 May 28.

PMID:
19493023
9.

Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia.

Winnett G, Nolan J, Miller M, Ashman N.

Nephrol Dial Transplant. 2008 Nov;23(11):3592-8. doi: 10.1093/ndt/gfn299. Epub 2008 May 25.

PMID:
18503094
10.

Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.

Labriola L, Crott R, Jadoul M.

Nephrol Dial Transplant. 2008 May;23(5):1666-72. Epub 2007 Dec 8.

PMID:
18065789
11.

A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.

Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schulz M, Diggle P.

Am J Kidney Dis. 2010 Jun;55(6):1060-8. doi: 10.1053/j.ajkd.2009.11.025. Epub 2010 Mar 6.

PMID:
20207458
12.

Antibiotic lock: in vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 degrees C.

Battistella M, Vercaigne LM, Cote D, Lok CE.

Hemodial Int. 2010 Jul;14(3):322-6. doi: 10.1111/j.1542-4758.2010.00440.x. Epub 2009 Mar 24.

PMID:
20345391
13.

Intra-catheter leukocyte culture to monitor hemodialysis catheter colonization. A prospective study to prevent catheter-related bloodstream infections.

Del Pozo JL, Aguinaga A, Garcia-Fernandez N, Hernaez S, Serrera A, Alonso M, Ramos A, Guillen-Grima F, Leiva J.

Int J Artif Organs. 2008 Sep;31(9):820-6.

PMID:
18924094
14.

A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.

Meeus G, Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y.

Blood Purif. 2005;23(2):101-5. Epub 2005 Jan 6.

PMID:
15640601
15.

Catheter-related bacteremia in hemodialysis: which preventive measures to take?

Silva J, Teixeira e Costa, Baptista A, Ramos A, Ponce P.

Nephron Clin Pract. 2008;110(4):c251-7. doi: 10.1159/000167873. Epub 2008 Oct 31.

PMID:
18974657
16.

[Catheter lock solution--taurolock for prevention of catheter-related bacteremia in hemodialysis patients].

Geron R, Tanchilevski O, Kristal B.

Harefuah. 2006 Dec;145(12):881-4, 943. Hebrew.

PMID:
17220025
17.
18.

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.

Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators..

Crit Care Med. 2011 Apr;39(4):613-20. doi: 10.1097/CCM.0b013e318206b5a2.

PMID:
21200319
19.

A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.

Zwiech R, Adelt M, Chrul S.

Am J Ther. 2016 Mar-Apr;23(2):e363-8. doi: 10.1097/MJT.0b013e31828d4610.

PMID:
23665885
20.

Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.

Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ; CITRATE Study Group..

J Am Soc Nephrol. 2005 Sep;16(9):2769-77. Epub 2005 Jul 20.

Supplemental Content

Support Center